BioSpectrum Asia

Acknowledgement/ Feedback

Quanterix loved Dr Michael Miller’s piece in the December issue of BioSpectrum Asia. We wish to continue collaborating with you in the new year! Thanks, BioSpectrum Asia for including inputs from Frost & Sullivan in your cover story. -Manikam,...

Acknowledgement/ Feedback

Thanks so much for the feature on Clarivate in BioSpectrum Asia’s November 2025 edition. This is fantastic. Thank you so much for creating such a fantastic article from the interview with Teijin. We look forward to continuing our collaboration in the...

Acknowledgement/ Feedback

In reference to BioSpectrum’s article- ‘How Asia is Pioneering Longevity Biotech’, the investment appetite and scientific talent emerging in Asia suggest it could set new global standards in healthy human longevity. Very promising direction. - Roberto...

Acknowledgement/ Feedback

Thank you for the interview feature on Connietec. It keeps us more motivated to supply better products through continuous supplementation and development. South Korea Thank you so much for publishing the article- ‘The Future Formula: What’s Driving...

“HSA is adopting a forward-looking 5P Strategy to tackle challenges”

Adjunct Professor (Dr) Raymond Chua, who stepped into his role as CEO of Singapore’s Health Sciences Authority (HSA) in December 2024, outlines the agency’s current priorities in positioning Singapore as a regional hub for biotech and medtech...

Acknowledgement/ Feedback

Thank you for including the comments by Bharat Biotech in your cover story on vaccines. Shilpi, India Thank you BioSpectrum Asia for publishing the interviewing with Orum Therapeutics. Jessica, UK Appreciation to BioSpectrum for carrying the article...

APAC VACCINE POWERHOUSES

Acknowledgement/ Feedback

Thank you BioSpectrum Asia for publishing Advarra's article on clinical trial management in the February 2025 edition. - Lisa, USA Thank you for including comments by Parexel in BioSpectrum Asia’s cover story on AI-driven drug discovery. - Emma,...

Acknowledgement/ Feedback

Much thanks BioSpectrum for featuring the article by Everest Group in the December 2024 edition. Everest Group’s Advanced SciTech (AST) team is focusing on identifying and assessing the impact of emerging trends, technologies, innovations and...

Acknowledgement/ Feedback

Thanks very much for your interest in the Sydney Vietnam Institute, and for the interview feature in BioSpectrum Asia. - Verity, Australia Many thanks to BioSpectrum Asia for taking the time to do an interview with Noxopharm. - Julian,...

Acknowledgement/ Feedback

Thanks BioSpectrum Asia for interviewing Medidata for your esteemed publication, for the October edition. - Aisyah, Singapore Thanks for incorporating comments from GeoVax in your cover story on monkeypox. Loved reading it. - Dave, USA Thanks so...

“Australia has long been a global leader in research, yet our biotech sector has not lived up to its full potential”

Australia's first true biotech incubator, Proto Axiom, has secured $20 million in the first close of its $30 million Series B round to strengthen the nation’s biotech sector through greater IP retention. Anthony Liveris, CEO of Proto Axio discusses the...

Acknowledgement/ Feedback

Thank you so much for the wonderful feature on ‘Why multi-use real estate is in demand for life sciences companies’. - Corrie Fisher, US Thank you BioSpectrum Asia for the interview feature on Lindström in the June edition, and for highlighting our...